Activity of AZD2563, a Novel Oxazolidinone, against Staphylococcus aureus Strains with Reduced Susceptibility to Vancomycin or Linezolid

The susceptibilities of clinical vancomycin-intermediate Staphylococcus aureus (VISA), heterogenous VISA, and laboratory-generated linezolid-resistant S. aureus strains to the new oxazolidinone AZD2563 were assessed by agar dilution MIC determination. All clinical strains were susceptible to linezol...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Howe, Robin A., Wootton, Mandy, Noel, Alan R., Bowker, Karen E., Walsh, Timothy R., MacGowan, Alasdair P.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC253812/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14576139/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.11.3651-3652.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!